| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Merck is experiencing significant advancements in product/service development, particularly in oncology, with a series of successful drug trials and robust product pipeline expansions. The company has achieved multiple positive outcomes in late-stage cancer trials, including notable results for Keytruda combinations. These developments reflect Merck's commitment to innovation and its strong position within the competitive landscape of cancer treatment. However, the constant challenge of regulatory hurdles and market competition remains a critical factor for the company's future growth. |
| The price action of MERCK & CO. INC. (MRK) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 3.4 is extremely bullish. The market sentiment at 1.1 is very bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. MRK is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1.5, and the negative at -0.4 on 2026-05-22. The forces of Stock Price Trend (3.4), Sentiment towards Fundamentals (2.6), Sector Price Trend (1.6), Option Sentiment (1.5), and Valuation Sentiment (0.6) will drive up the price. The forces of Market Risk Appetite (-0.9), and Price Level Sentiment (-1.5) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| MRK | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | 0%(0%) | 122.42 | 2.19% | 140 | 5.65% | 0.97% | 3.4 | 0.9 | 3.2% | 1.1 | Wait | 50% | 2.6 | 7 |
| 2026-05-21 | 0%(0%) | 115.87 | 1.32% | 108 | 2.54% | 0.36% | 0.9 | 0.5 | 0.8% | 0.3 | Wait | 50% | 0.7 | -1 |
| 2026-05-20 | 0%(0%) | 113.01 | 1.24% | 64 | -1.11% | -0.09% | -0.2 | -0.2 | 0.7% | 0.5 | Short | 55% | 0.8 | -1 |
| 2026-05-19 | 0%(0%) | 114.27 | 1.22% | 87 | 1.52% | 0.09% | 0.6 | 0.4 | 1.1% | 0.4 | Long | 55% | 0.7 | -1 |
| 2026-05-18 | 0%(0%) | 112.56 | 1.17% | 59 | 1.05% | 0% | -0.1 | 0.4 | 0.6% | 0.2 | Long | 55% | 0.7 | -1 |
| 2026-05-17 | 0%(0%) | -0.4 | 0.4 | -0 | 0.4 | -1 | ||||||||
| 2026-05-16 | 0%(0%) | -0.4 | 0.4 | -0 | 0.4 | -1 | ||||||||
| 2026-05-15 | 0%(0%) | 111.39 | 1.54% | 35 | -1.79% | -0.09% | -0.4 | -0.2 | 0.8% | 0.2 | Short | 55% | 0.4 | -1 |
| 2026-05-14 | 0%(0%) | 113.42 | 1.97% | 58 | -0.04% | 0.36% | 0.5 | 0.2 | 0.3% | 0.6 | Long | 55% | 0.7 | -1 |
| 2026-05-13 | 0%(0%) | 113.47 | 2.03% | 57 | 0.97% | 0.18% | -0.1 | 0.3 | 0.6% | 0.3 | Long | 55% | 1.2 | -1 |
| Wait is the preferred trading strategy with 50% chance of being right. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| 2026-05-22 17:02:18 Collaborations with companies like Kelun-Biotech and ongoing partnerships are facilitating innovation in developing effective cancer treatments, enhancing Merck's portfolio. |
| 2026-05-22 17:02:18 Weak sales performance of Merck's Gardasil vaccine due to external market factors highlights ongoing challenges the company faces in its vaccine division. |
| 2026-05-22 17:02:18 Recent approvals and positive opinions from regulatory agencies regarding Merck’s treatments signify strong validation of their product portfolio. |
| 2026-05-22 17:02:18 Positive developments in clinical trials and regulatory approvals have led to significant increases in Merck's stock price, reflecting investor confidence. |
| 2026-05-22 17:02:18 Recent studies and trials showcasing promising results in cancer treatments involving Merck’s Keytruda and collaborations with partners are indicative of ongoing advancements in cancer therapies. |
| 2026-05-22 15:47:55 The positive performance of individual companies like Merck and Caterpillar is noted as a significant factor in the overall market rally. |
| 2026-05-22 15:47:55 The article highlights a significant rally in the Dow Jones Industrial Average driven by strong performances from specific stocks. |
| 2026-05-22 13:48:10 The article mentions Merck's partnership with Kelun-Biotech which resulted in significant advancements in cancer treatment. |
| 2026-05-22 13:48:10 Merck's stock experienced a rise following the positive trial results, reflecting investor confidence and strong stock performance. |
| 2026-05-22 13:48:10 The article highlights the positive late-stage trial results of a Keytruda combination treatment in lung cancer, indicating successful development in the pharmaceutical industry. |